Study on HPV after cone biopsy for cervical cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This study looks at women with early-stage cervical cancer (stage IB2) or a pre-cancer called AIS. The goal is to see if testing for HPV after a cone biopsy can help predict if the cancer will come back. Your HPV test results will be tracked over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 85 years old.
- You have early-stage cervical cancer (stage IB2, tumor up to 4 cm) or a pre-cancerous condition called AIS (adenocarcinoma in situ).
- You are scheduled to have a cone biopsy (a small surgery to remove a cone-shaped piece of tissue from the cervix).
- You have had an HPV test before your cone biopsy.
- You are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how to sort people into higher- or lower-risk groups after abnormal HPV testing treatment (LEEP), using repeat HPV and Pap (cytology) tests. It may help improve follow-up plans by identifying who needs closer monitoring after LEEP.
This Phase 3 study tests whether giving additional (adjuvant) chemotherapy after standard chemoradiation can help people whose blood test still shows cancer-related HPV DNA. It may help by lowering the risk of the cervical cancer coming back in people who have a positive blood biomarker after treatment.
This study tests whether removing a small piece of the cervix (cone biopsy) can help diagnose hidden precancer when regular tests are unclear. It may help you get a clearer diagnosis if you have ongoing HPV or abnormal cell changes.
This trial tests whether giving an HPV vaccine after a cone biopsy (a surgery to remove abnormal cells from the cervix) helps prevent the HPV-related disease from coming back. It may be an option for patients who have had treatment for cervical dysplasia and have not been vaccinated against HPV before.
This study looks at whether HPV infection stays in the body during and after standard radiation treatment for cervical cancer, and if that affects how well the treatment works. It aims to understand more about why some people respond better than others.
This trial studies a blood test that looks for HPV DNA after cervical cancer surgery. The test may help doctors predict if the cancer might come back and decide if more treatment is needed.
Hear when a new Cervix Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.